Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study

Ali Bazarbachi, Ariane Boumendil, Hervé Finel, Luca Castagna, Alida Dominietto, Didier Blaise, Jose L. Diez-Martin, Johanna Tischer, Zafer Gülbas, Hélène L. Wallet, Lucia L. Corral, Mohamad Mohty, Yener Koc, Ibrahim Yakoub-Agha, Christoph Schmid, Jean El Cheikh, Mutlu Arat, Edouard Forcade, Peter Dreger, Vanderson RochaGonzalo G. García, Yves Chalandon, Christelle Ferra, Corentin Orvain, Stephen Robinson, Silvia Montoto, Anna Sureda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Haploidentical stem cell transplantation (haploSCT) is becoming a major transplant modality for lymphoma. To assess the effects of donor characteristics, stem cell source and conditioning on outcomes, we identified 474 adults with Hodgkin (HL; 240), peripheral T-cell (PTCL; 88), diffuse large B-cell (77), mantle cell (40) or follicular lymphoma (FL; 29), who received haploSCT with post-transplant cyclophosphamide. Median follow-up of alive patients was 32 months. On multivariate analysis, acute graft-versus-host disease (GVHD) grade 2–4 was lower with offspring donors or bone marrow cells, whereas extensive chronic GVHD was higher in partial response at haploSCT or when using sisters, haploidentical donors beyond first degree, or female donors in male patients. Progression-free survival (PFS) was better for FL, HL and PTCL, whereas overall survival (OS) was better for HL and PTCL. Complete remission at haploSCT improved PFS and OS whereas these were negatively affected by cytomegalovirus donor positive/recipient positive status. No other donor characteristics (age, gender, human leucocyte antigen mismatch, ABO incompatibility) affected PFS or OS except use of haploidentical donors beyond first degree, which negatively affected OS. PFS and OS are mostly influenced by disease status and lymphoma subtype, supporting the use of any first degree haploidentical family member as a donor.

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Lymphoma
Stem Cells
Tissue Donors
Transplants
Stem Cell Transplantation
Disease-Free Survival
Survival
Graft vs Host Disease
Mantle-Cell Lymphoma
Follicular Lymphoma
Conditioning (Psychology)
HLA Antigens
Cytomegalovirus
Hodgkin Disease
Bone Marrow Cells
Cyclophosphamide
Siblings
B-Lymphocytes
Multivariate Analysis
T-Lymphocytes

Keywords

  • conditioning
  • donor type
  • haploidentical transplant
  • lymphoma
  • stem cell source

ASJC Scopus subject areas

  • Hematology

Cite this

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study. / Bazarbachi, Ali; Boumendil, Ariane; Finel, Hervé; Castagna, Luca; Dominietto, Alida; Blaise, Didier; Diez-Martin, Jose L.; Tischer, Johanna; Gülbas, Zafer; Wallet, Hélène L.; Corral, Lucia L.; Mohty, Mohamad; Koc, Yener; Yakoub-Agha, Ibrahim; Schmid, Christoph; El Cheikh, Jean; Arat, Mutlu; Forcade, Edouard; Dreger, Peter; Rocha, Vanderson; García, Gonzalo G.; Chalandon, Yves; Ferra, Christelle; Orvain, Corentin; Robinson, Stephen; Montoto, Silvia; Sureda, Anna.

In: British Journal of Haematology, 01.01.2019.

Research output: Contribution to journalArticle

Bazarbachi, A, Boumendil, A, Finel, H, Castagna, L, Dominietto, A, Blaise, D, Diez-Martin, JL, Tischer, J, Gülbas, Z, Wallet, HL, Corral, LL, Mohty, M, Koc, Y, Yakoub-Agha, I, Schmid, C, El Cheikh, J, Arat, M, Forcade, E, Dreger, P, Rocha, V, García, GG, Chalandon, Y, Ferra, C, Orvain, C, Robinson, S, Montoto, S & Sureda, A 2019, 'Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study', British Journal of Haematology. https://doi.org/10.1111/bjh.16182
Bazarbachi, Ali ; Boumendil, Ariane ; Finel, Hervé ; Castagna, Luca ; Dominietto, Alida ; Blaise, Didier ; Diez-Martin, Jose L. ; Tischer, Johanna ; Gülbas, Zafer ; Wallet, Hélène L. ; Corral, Lucia L. ; Mohty, Mohamad ; Koc, Yener ; Yakoub-Agha, Ibrahim ; Schmid, Christoph ; El Cheikh, Jean ; Arat, Mutlu ; Forcade, Edouard ; Dreger, Peter ; Rocha, Vanderson ; García, Gonzalo G. ; Chalandon, Yves ; Ferra, Christelle ; Orvain, Corentin ; Robinson, Stephen ; Montoto, Silvia ; Sureda, Anna. / Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study. In: British Journal of Haematology. 2019.
@article{9573e67d30a444ddb9ec19863cf99aec,
title = "Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study",
abstract = "Haploidentical stem cell transplantation (haploSCT) is becoming a major transplant modality for lymphoma. To assess the effects of donor characteristics, stem cell source and conditioning on outcomes, we identified 474 adults with Hodgkin (HL; 240), peripheral T-cell (PTCL; 88), diffuse large B-cell (77), mantle cell (40) or follicular lymphoma (FL; 29), who received haploSCT with post-transplant cyclophosphamide. Median follow-up of alive patients was 32 months. On multivariate analysis, acute graft-versus-host disease (GVHD) grade 2–4 was lower with offspring donors or bone marrow cells, whereas extensive chronic GVHD was higher in partial response at haploSCT or when using sisters, haploidentical donors beyond first degree, or female donors in male patients. Progression-free survival (PFS) was better for FL, HL and PTCL, whereas overall survival (OS) was better for HL and PTCL. Complete remission at haploSCT improved PFS and OS whereas these were negatively affected by cytomegalovirus donor positive/recipient positive status. No other donor characteristics (age, gender, human leucocyte antigen mismatch, ABO incompatibility) affected PFS or OS except use of haploidentical donors beyond first degree, which negatively affected OS. PFS and OS are mostly influenced by disease status and lymphoma subtype, supporting the use of any first degree haploidentical family member as a donor.",
keywords = "conditioning, donor type, haploidentical transplant, lymphoma, stem cell source",
author = "Ali Bazarbachi and Ariane Boumendil and Herv{\'e} Finel and Luca Castagna and Alida Dominietto and Didier Blaise and Diez-Martin, {Jose L.} and Johanna Tischer and Zafer G{\"u}lbas and Wallet, {H{\'e}l{\`e}ne L.} and Corral, {Lucia L.} and Mohamad Mohty and Yener Koc and Ibrahim Yakoub-Agha and Christoph Schmid and {El Cheikh}, Jean and Mutlu Arat and Edouard Forcade and Peter Dreger and Vanderson Rocha and Garc{\'i}a, {Gonzalo G.} and Yves Chalandon and Christelle Ferra and Corentin Orvain and Stephen Robinson and Silvia Montoto and Anna Sureda",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/bjh.16182",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study

AU - Bazarbachi, Ali

AU - Boumendil, Ariane

AU - Finel, Hervé

AU - Castagna, Luca

AU - Dominietto, Alida

AU - Blaise, Didier

AU - Diez-Martin, Jose L.

AU - Tischer, Johanna

AU - Gülbas, Zafer

AU - Wallet, Hélène L.

AU - Corral, Lucia L.

AU - Mohty, Mohamad

AU - Koc, Yener

AU - Yakoub-Agha, Ibrahim

AU - Schmid, Christoph

AU - El Cheikh, Jean

AU - Arat, Mutlu

AU - Forcade, Edouard

AU - Dreger, Peter

AU - Rocha, Vanderson

AU - García, Gonzalo G.

AU - Chalandon, Yves

AU - Ferra, Christelle

AU - Orvain, Corentin

AU - Robinson, Stephen

AU - Montoto, Silvia

AU - Sureda, Anna

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Haploidentical stem cell transplantation (haploSCT) is becoming a major transplant modality for lymphoma. To assess the effects of donor characteristics, stem cell source and conditioning on outcomes, we identified 474 adults with Hodgkin (HL; 240), peripheral T-cell (PTCL; 88), diffuse large B-cell (77), mantle cell (40) or follicular lymphoma (FL; 29), who received haploSCT with post-transplant cyclophosphamide. Median follow-up of alive patients was 32 months. On multivariate analysis, acute graft-versus-host disease (GVHD) grade 2–4 was lower with offspring donors or bone marrow cells, whereas extensive chronic GVHD was higher in partial response at haploSCT or when using sisters, haploidentical donors beyond first degree, or female donors in male patients. Progression-free survival (PFS) was better for FL, HL and PTCL, whereas overall survival (OS) was better for HL and PTCL. Complete remission at haploSCT improved PFS and OS whereas these were negatively affected by cytomegalovirus donor positive/recipient positive status. No other donor characteristics (age, gender, human leucocyte antigen mismatch, ABO incompatibility) affected PFS or OS except use of haploidentical donors beyond first degree, which negatively affected OS. PFS and OS are mostly influenced by disease status and lymphoma subtype, supporting the use of any first degree haploidentical family member as a donor.

AB - Haploidentical stem cell transplantation (haploSCT) is becoming a major transplant modality for lymphoma. To assess the effects of donor characteristics, stem cell source and conditioning on outcomes, we identified 474 adults with Hodgkin (HL; 240), peripheral T-cell (PTCL; 88), diffuse large B-cell (77), mantle cell (40) or follicular lymphoma (FL; 29), who received haploSCT with post-transplant cyclophosphamide. Median follow-up of alive patients was 32 months. On multivariate analysis, acute graft-versus-host disease (GVHD) grade 2–4 was lower with offspring donors or bone marrow cells, whereas extensive chronic GVHD was higher in partial response at haploSCT or when using sisters, haploidentical donors beyond first degree, or female donors in male patients. Progression-free survival (PFS) was better for FL, HL and PTCL, whereas overall survival (OS) was better for HL and PTCL. Complete remission at haploSCT improved PFS and OS whereas these were negatively affected by cytomegalovirus donor positive/recipient positive status. No other donor characteristics (age, gender, human leucocyte antigen mismatch, ABO incompatibility) affected PFS or OS except use of haploidentical donors beyond first degree, which negatively affected OS. PFS and OS are mostly influenced by disease status and lymphoma subtype, supporting the use of any first degree haploidentical family member as a donor.

KW - conditioning

KW - donor type

KW - haploidentical transplant

KW - lymphoma

KW - stem cell source

UR - http://www.scopus.com/inward/record.url?scp=85071415694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071415694&partnerID=8YFLogxK

U2 - 10.1111/bjh.16182

DO - 10.1111/bjh.16182

M3 - Article

C2 - 31498883

AN - SCOPUS:85071415694

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -